|
|
|
Corporate Profile: Acorda
Therapeutics
| Summary: |
| Acorda
Therapeutics, Inc. was established in March 1995
to develop therapeutic products for spinal cord
injury ("SCI") and other central nervous system
disorders. Acorda is focusing its initial development
efforts on a range of therapeutics for individuals
with chronic, or long term, SCI. Currently, there
is no therapy that improves neurological function
in chronic SCI patients. |
| Address (HQ): |
420 Saw Mill River Road
Ardsley, NY 10502 |
| Phone #'s (HQ): |
| Main |
(914) 347-4300 |
| Human
Resources |
not known |
| Investor
Relations |
(914) 347-4300 |
| Fax #'s (HQ): |
| Main |
(914) 347-4560 |
| Human
Resources |
(914) 347-4560 |
| Investor
Relations |
not known |
| Financial
information: |
| ACOR |
| Issued United States patents: |
| Issued U.S.
patents 1976-present: patent
link. |
| Filed United States patent applications: |
| Filed U.S. patent applications: 2001-present: patent
link. |
| Publications on PubMed: |
| Scientific publications on PubMed with an author from the company: publications
link. |
|
|
|
